First Finding of a Methicillin-Resistant Staphylococcus aureus (MRSA) t304/ST6 from Bovine Clinical Mastitis

Desiree Corvera Kløve1, Vibeke Frøkjær Jensen1, Lærke Boye Astrup1

  • 1Center for Diagnostics, Technical University of Denmark, Kemitorvet, 2800 Kgs. Lyngby, Denmark.

Insights

The first bovine clinical mastitis case of the MRSA t304/ST6 variant was identified. This suggests a potential human-to-cow transmission event, highlighting the need for antimicrobial resistance surveillance in livestock.

Area of Science:

  • Veterinary Microbiology
  • Antimicrobial Resistance
  • One Health

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat to both humans and animals.
  • The MRSA t304/ST6 variant is commonly found in human infections but rarely reported in livestock.

Purpose of the Study:

  • To report and characterize the first occurrence of the MRSA t304/ST6 variant in a bovine clinical mastitis case.
  • To investigate the genetic and phenotypic characteristics of this bovine MRSA isolate.

Main Methods:

  • Phenotypic and genotypic resistance profiling of the bovine MRSA isolate.
  • Analysis of the isolate's genetic makeup, including SCCmec type, plasmid content, and prophage presence.
  • Comparison of genetic elements with known human MRSA strains.

Main Results:

  • The bovine MRSA t304/ST6 isolate exhibited low susceptibility to cefoxitin (MIC=16 µg/mL) and possessed the mecA gene within SCCmec IVa.
  • The isolate harbored a plasmid similar to those found in human MRSA t304/ST6 strains and a Staphylococcus prophage 3 (ϕSA3) encoding an immune evasion cluster (IEC).
  • The presence of human-associated virulence genes (sea, sak, scn) suggests a recent human-to-cow host jump.

Conclusions:

  • The findings indicate a likely recent transmission of MRSA t304/ST6 from humans to cattle.
  • This study underscores the critical need for robust antimicrobial resistance surveillance programs targeting bovine mastitis pathogens like Staphylococcus aureus and MRSA.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...